Rheumatology Research Group
Our research has a major focus on inflammatory rheumatic diseases; in particular the pathobiology, comorbidity and patient reported outcomes associated with rheumatoid arthritis, Sjogren’s syndrome and systemic lupus erythematosus, as well as their epidemiology and clinical management. We are a substantial multidisciplinary team including academic/clinical rheumatologists, general practitioners, biological/behavioural scientists, allied health professionals and patient research partners.
- To improve clinical outcomes for those with, and at risk of developing, rheumatoid arthritis (RA), Sjogren’s syndrome (SS) and systemic lupus erythematosus (SLE)
- To discover and improve tests used to make diagnoses and to predict disease course from the earliest stages of symptoms
- To explore therapeutic targeting of the tissue microenvironment and compare and contrast the biological processes underpinning the development, maintenance and resolution of inflammation
- To compare shared biological mechanisms across a number of traditionally independent organ based medical disciplines in order to develop biologically meaningful and therapeutically tractable process-driven links to other disease areas in inflammation biology